Durvalumab vs Levofloxacin

## Durvalumab vs Levofloxacin: Overview

This comparison examines the pharmacological differences between **Durvalumab** and **Levofloxacin**.

## Mechanism of Action

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

**Levofloxacin**: Fluoroquinolone antibiotic inhibiting bacterial DNA gyrase and topoisomerase IV.

## Pharmacokinetics

**Half-life**: Durvalumab — 17 days; Levofloxacin — 6-8 hours.

## Chemical Properties

**Molecular Formula**: Durvalumab — N/A; Levofloxacin — C18H20FN3O4.

**Molecular Weight**: Durvalumab — N/A; Levofloxacin — 361.3680 g/mol.

**Type**: Durvalumab — Antibody; Levofloxacin — Small molecule.